235. Tracking Invasive Extraintestinal Pathogenic Escherichia coli Disease in Older Adults in a Community-Based Clinical Trial Setting

BACKGROUND: A vaccine developed to prevent invasive extraintestinal pathogenic Escherichia coli disease (IED) is being evaluated in a phase 3 clinical trial (NCT04899336). However, historical performance of similar clinical trials has been challenged by inefficient endpoint catchment. Here we report...

Descripción completa

Detalles Bibliográficos
Autores principales: Doua, Joachim, Ekkelenkamp, Miquel, Ruhmel, Stephen, Leathers, Kimberly, Associate, Clinical Research, Go, Oscar, Chatterjee, Ranee, Sarnecki, Michal, Poolman, Jan, Bonten, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752203/
http://dx.doi.org/10.1093/ofid/ofac492.313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752203/
http://dx.doi.org/10.1093/ofid/ofac492.313

Ejemplares similares